Early Commercial Lead - Fibrostenosing Crohn’s Disease
agomab
About this role
A Commercial Lead role focused on shaping the commercial strategy for Ontunisertib, a Phase 2b development drug for Fibrostenosing Crohn’s Disease. The role involves defining the value proposition, positioning, and evidence strategy for the drug as it progresses through clinical development.
Skills
About agomab
agomab.comAgomab Therapeutics is a biotechnology company focused on developing therapies to treat fibrotic diseases. The company translates cutting-edge scientific insights into disease-modifying treatments, aiming to halt or reverse fibrosis across organs such as the liver, lungs, and kidneys. With a research-driven culture, Agomab collaborates with academic and industry partners to advance a pipeline from discovery through development. The goal is to deliver impactful medicines that improve outcomes for patients suffering from fibrosis.
About agomab
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for agomab.
More jobs at agomab
Similar Jobs
Section Lead & Center of Excellence (CoE) Strategy Realization
Roche
Medical Director, Kidney Disease, Early Clinical Development CVRM
AstraZeneca
Executive Medical Director, Gastroenterology, Early R&I Clinical Development
AstraZeneca
Executive Medical Director, Rheumatology, Global Medical Affairs
Zenas BioPharma
Lead – Evidence Analysis (Ortho)
Smith & Nephew
Commercial Marketing Lead - Haemophilia
Roche